IT1404011B1 - Nanovettore coniugato con tsh per il trattamento del cancro della tiroide - Google Patents
Nanovettore coniugato con tsh per il trattamento del cancro della tiroideInfo
- Publication number
- IT1404011B1 IT1404011B1 ITRM2010A000629A ITRM20100629A IT1404011B1 IT 1404011 B1 IT1404011 B1 IT 1404011B1 IT RM2010A000629 A ITRM2010A000629 A IT RM2010A000629A IT RM20100629 A ITRM20100629 A IT RM20100629A IT 1404011 B1 IT1404011 B1 IT 1404011B1
- Authority
- IT
- Italy
- Prior art keywords
- nanovector
- tsh
- conjugated
- treatment
- thyroid cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM2010A000629A IT1404011B1 (it) | 2010-12-03 | 2010-12-03 | Nanovettore coniugato con tsh per il trattamento del cancro della tiroide |
| PCT/IB2011/052816 WO2012073125A1 (en) | 2010-12-03 | 2011-06-27 | Tsh-conjugated nanocarrier for the treatment of thyroid cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM2010A000629A IT1404011B1 (it) | 2010-12-03 | 2010-12-03 | Nanovettore coniugato con tsh per il trattamento del cancro della tiroide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITRM20100629A1 ITRM20100629A1 (it) | 2012-06-04 |
| IT1404011B1 true IT1404011B1 (it) | 2013-11-08 |
Family
ID=43737260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITRM2010A000629A IT1404011B1 (it) | 2010-12-03 | 2010-12-03 | Nanovettore coniugato con tsh per il trattamento del cancro della tiroide |
Country Status (2)
| Country | Link |
|---|---|
| IT (1) | IT1404011B1 (it) |
| WO (1) | WO2012073125A1 (it) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6255348B2 (ja) * | 2011-12-19 | 2017-12-27 | ジェンザイム・コーポレーション | 甲状腺刺激ホルモン組成物 |
| CN103110931B (zh) * | 2013-03-19 | 2015-08-19 | 广州迈达康医药科技有限公司 | 制备罗咪酯肽脂质体的方法 |
| WO2015117136A1 (en) | 2014-02-03 | 2015-08-06 | Ohio State Innovation Foundation | Boronic acid esters and pharmaceutical formulations thereof |
| CN112656764B (zh) * | 2020-12-28 | 2022-09-02 | 吉林大学 | 一种紫杉醇铂类共载靶向长循环脂质体及应用 |
| IL316061A (en) | 2022-04-22 | 2024-11-01 | Universit?T Heidelberg | The composition including cytidine analogs and their uses and methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH672733A5 (it) | 1987-05-22 | 1989-12-29 | Bracco Ind Chimica Spa | |
| DE4402867C1 (de) * | 1994-01-31 | 1995-06-14 | Rentschler Arzneimittel | Liposomen enthaltend darin verkapselte Proteine, Verfahren zu ihrer Herstellung sowie diese Liposomen enthaltende pharmazeutische und kosmetische Zubereitungen |
| DE4432378A1 (de) | 1994-09-12 | 1996-03-14 | Bayer Ag | Injizierbare liposomale Arzneizubereitungen |
| EP1868572A4 (en) | 2005-03-29 | 2011-03-09 | F Timothy Guilford | ADMINISTRATION OF GLUTATHION (REDUCED) ON THE INTRAVENOUS WAY OR CAPSULATED IN A LIPOSOME FOR THE TREATMENT OF TNF ALPHA EFFECTS AND FLUID VIRAL SYMPTOMS |
| WO2007031333A2 (en) | 2005-09-15 | 2007-03-22 | Novosom Ag | Improvements in or relating to amphoteric liposomes |
| WO2007094395A1 (ja) | 2006-02-15 | 2007-08-23 | Mie University | 診断用組換えプロテオリポソームの作製法 |
| EP4241767B1 (en) * | 2008-11-10 | 2024-10-23 | Arbutus Biopharma Corporation | Novel lipids and compositions for the delivery of therapeutics |
-
2010
- 2010-12-03 IT ITRM2010A000629A patent/IT1404011B1/it active
-
2011
- 2011-06-27 WO PCT/IB2011/052816 patent/WO2012073125A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012073125A1 (en) | 2012-06-07 |
| ITRM20100629A1 (it) | 2012-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289300A (en) | Combination therapy for treating cancer | |
| IL224370B (en) | Combination treatment for prostate carcinoma | |
| HUE047198T2 (hu) | Fitokannabinoidok emlõrák kezelésére | |
| HUE048876T2 (hu) | Rákos megbetegedések kezelése | |
| HUE040524T2 (hu) | Mellrák kezelése | |
| BR112014007603A2 (pt) | métodos de tratamento do câncer | |
| HUE046667T2 (hu) | Rák kombinatív kezelése | |
| BR112013024211A2 (pt) | tratamento de tumores sólidos | |
| BR112014012880A2 (pt) | tratamento imunogênico do câncer | |
| DK3055331T3 (da) | Konjugerede antistoffer mod ly75 til cancerbehandling | |
| IL226246A0 (en) | Methods of treating cancer | |
| IL228430A0 (en) | Cancer treatment | |
| SMT201600235B (it) | Predittori per il trattamento del cancro | |
| SMT201600253B (it) | Terapia di combinazione per il trattamento del cancro della mammella | |
| SI2892925T1 (sl) | Kombinacijsko zdravljenje raka | |
| FI20115551L (fi) | Koaksiaaliliitin | |
| EP2585115A4 (en) | Cancer therapy | |
| EP2575459A4 (en) | CANCER TREATMENT WITH WORDMAN ANALOGA | |
| PL2726880T3 (pl) | Leczenie nowotworu prostaty i sposób określania prognozy dla pacjentów z nowotworem prostaty | |
| ME03035B (me) | Kombinacijska terapija raka jajnika | |
| GB201121783D0 (en) | Treatment of cancer | |
| GB201121791D0 (en) | Combination treatment of cancer | |
| GB201017354D0 (en) | Treatment of cancer |